Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study

BACKGROUND: This randomized, double-blind, Phase IIIb study evaluated the 24-hour bronchodilatory efficacy of aclidinium bromide versus placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). Methods: Patients received aclidinium 400 μg twice daily (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Beier, Jutta, Kirsten, Anne-Marie, Mróz, Robert, Segarra, Rosa, Chuecos, Ferran, Caracta, Cynthia, Gil, Esther Garcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787813/
https://www.ncbi.nlm.nih.gov/pubmed/23819698
http://dx.doi.org/10.3109/15412555.2013.814626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787813/
https://www.ncbi.nlm.nih.gov/pubmed/23819698
http://dx.doi.org/10.3109/15412555.2013.814626

Ejemplares similares